Infliximab (anti-TNF-alpha)
Catalogue Number: A2019-SEL
| Manufacturer: | Selleck Chemicals |
| Type: | Recombinant Monoclonal |
| Shipping Condition: | Dry Ice |
| Unit(s): | 5 mg, 1 mg, 25 x 1 mg |
Description
Description: Infliximab (anti-TNF-alpha) is a purified, recombinant DNA-derived chimeric human-mouse IgG monoclonal antibody that consists of mouse heavy and light chain variable regions combined with human heavy and light chain constant regions. Infliximab neutralizes the biological activity of TNF-αby binding with high affinity to the soluble and transmembrane forms of TNF-α, and inhibits or prevents the effective binding of TNF-α with its receptors. MW=144.2 kDa.
Additional Text
CAS Number
170277-31-3
A2019 MSDS
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations